Skip to content
PubMed This is a summary of 39 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 39 referenced papers

Top Authors

Paula M. Oliver
Children's Hospital of Philadelphia
Andrew Richard Gennery
Great North Children's Hospital
Mary Anne Slatter
Great North Children's Hospital
Troy R. Torgerson
Allen Institute for Immunology
Jennifer R. Heimall
Children's Hospital of Philadelphia
Emily K. Moser
University of Florida
Alice Y. K. Chan
University of California, San Francisco
Kathleen E. Sullivan
Children's Hospital of Philadelphia
Hassan Abolhassani
Karolinska University Hospital
Emma C. Morris
University College London Hospitals NHS Foundation Trust

Top Institutions

Ranked by publications Top 10 institutions
07

Allen Institute for Immunology

Seattle, United States

26 papers
Contributors Troy R. Torgerson
08

National Cancer Institute

Bethesda, United States

15 papers
09

University of Florida

Gainesville, United States

8 papers

References

References (39)
  1. 1

    The E3 ligase Itch in immune regulation and beyond.

    Aki D, Zhang W, Liu YC

    Immunological reviews 2015; (266(1)):6-26 doi:10.1111/imr.12301.

    PMID: 26085204
  2. 2

    An IκB Kinase-Regulated Feedforward Circuit Prolongs Inflammation.

    Perez JM, Chirieleison SM, Abbott DW

    Cell reports 2015; (12(4)):537-44.

    PMID: 26190110
  3. 3

    Itch WW Domains Inhibit Its E3 Ubiquitin Ligase Activity by Blocking E2-E3 Ligase Trans-thiolation.

    Riling C, Kamadurai H, Kumar S, et al.

    The Journal of biological chemistry 2015; (290(39)):23875-87 doi:10.1074/jbc.M115.649269.

    PMID: 26245901
  4. 4

    Structural basis for the regulatory role of the PPxY motifs in the thioredoxin-interacting protein TXNIP.

    Liu Y, Lau J, Li W, et al.

    The Biochemical journal 2016; (473(2)):179-87 doi:10.1042/BJ20150830.

    PMID: 26527736
  5. 5

    Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination.

    Kathania M, Khare P, Zeng M, et al.

    Nature immunology 2016; (17(8)):997-1004 doi:10.1038/ni.3488.

    PMID: 27322655
  6. 6

    Vaccination in Primary Immunodeficiency Disorders.

    Sobh A, Bonilla FA

    The journal of allergy and clinical immunology. In practice 2016; (4(6)):1066-1075 doi:10.1016/j.jaip.2016.09.012.

    PMID: 27836056
  7. 7

    Phosphorylation of the E3 ubiquitin protein ligase ITCH diminishes binding to its cognate E2 ubiquitin ligase.

    Perez JM, Chen Y, Xiao TS, Abbott DW

    The Journal of biological chemistry 2018; (293(3)):1100-1105 doi:10.1074/jbc.RA117.000408.

    PMID: 29212706
  8. 8

    Primary immunodeficiency diseases in lung disease: warning signs, diagnosis and management.

    Soler-Palacín P, de Gracia J, González-Granado LI, et al.

    Respiratory research 2018; (19(1)):219 doi:10.1186/s12931-018-0923-8.

    PMID: 30419907
  9. 9

    Mutation in ITCH Gene Can Cause Syndromic Multisystem Autoimmune Disease With Acute Liver Failure.

    Kleine-Eggebrecht N, Staufner C, Kathemann S, et al.

    Pediatrics 2019; (143(2)) doi:10.1542/peds.2018-1554.

    PMID: 30705142
  10. 10

    Biallelic human ITCH variants causing a multisystem disease with dysmorphic features: A second report.

    Brittain HK, Feary J, Rosenthal M, et al.

    American journal of medical genetics. Part A 2019; (179(7)):1346-1350 doi:10.1002/ajmg.a.61169.

    PMID: 31091003
  11. 11

    The E3 ubiquitin ligase Itch restricts antigen-driven B cell responses.

    Moser EK, Roof J, Dybas JM, et al.

    The Journal of experimental medicine 2019; (216(9)):2170-2183 doi:10.1084/jem.20181953.

    PMID: 31311822
  12. 12

    Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.

    Ouahed J, Spencer E, Kotlarz D, et al.

    Inflammatory bowel diseases 2020; (26(6)):820-842 doi:10.1093/ibd/izz259.

    PMID: 31833544
  13. 13

    Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia.

    Fekrvand S, Yazdani R, Olbrich P, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2020; (31(4)):405-417 doi:10.1111/pai.13228.

    PMID: 32058651
  14. 14

    Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.

    Chan AY, Leiding JW, Liu X, et al.

    Frontiers in immunology 2020; (11()):239 doi:10.3389/fimmu.2020.00239.

    PMID: 32153572
  15. 15

    Itch regulation of innate and adaptive immune responses in mice and humans.

    Field NS, Moser EK, Oliver PM

    Journal of leukocyte biology 2020; (108(1)):353-362 doi:10.1002/JLB.3MIR0320-272R.

    PMID: 32356405
  16. 16

    Primary immune regulatory disorders: a growing universe of immune dysregulation.

    Chan AY, Torgerson TR

    Current opinion in allergy and clinical immunology 2020; (20(6)):582-590 doi:10.1097/ACI.0000000000000689.

    PMID: 32941318
  17. 17

    Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiency.

    Krone KA, Winant AJ, Vargas SO, et al.

    Pediatric pulmonology 2021; (56(7)):2232-2241 doi:10.1002/ppul.25373.

    PMID: 33710794
  18. 18

    Immune Dysregulation in Human ITCH Deficiency Successfully Treated with Hematopoietic Cell Transplantation.

    Patel T, Henrickson SE, Moser EK, et al.

    The journal of allergy and clinical immunology. In practice 2021; (9(7)):2885-2893.e3 doi:10.1016/j.jaip.2021.04.010.

    PMID: 33894394
  19. 19

    Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.

    Baron F, Canti L, Ariën KK, et al.

    Frontiers in immunology 2022; (13()):827242 doi:10.3389/fimmu.2022.827242.

    PMID: 35309332
  20. 20

    Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood.

    Day JW, Elfeky R, Nicholson B, et al.

    Journal of clinical immunology 2022; (42(6)):1230-1243 doi:10.1007/s10875-022-01278-6.

    PMID: 35579633
  21. 21

    Immunosuppression in Patients With Primary Immunodeficiency-Walking the Line.

    Mustafa SS, Rider NL, Jolles S

    The journal of allergy and clinical immunology. In practice 2022; (10(12)):3088-3096 doi:10.1016/j.jaip.2022.08.025.

    PMID: 36049628
  22. 22

    ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction.

    Wolfe R, Heiman P, D'Annibale O, et al.

    Molecular genetics and metabolism reports 2022; (33()):100932 doi:10.1016/j.ymgmr.2022.100932.

    PMID: 36338154
  23. 23

    Too much of a good thing: a review of primary immune regulatory disorders.

    Tsilifis C, Slatter MA, Gennery AR

    Frontiers in immunology 2023; (14()):1279201 doi:10.3389/fimmu.2023.1279201.

    PMID: 38022498
  24. 24

    Infections in Disorders of Immune Regulation.

    Thangaraj A, Tyagi R, Suri D, Gupta S

    Pathogens (Basel, Switzerland) 2024; (13(3)) doi:10.3390/pathogens13030259.

    PMID: 38535602
  25. 25

    Innovations in the care of childhood interstitial lung disease associated with connective tissue disease and immune-mediated disorders.

    Samad A, Wobma H, Casey A

    Pediatric pulmonology 2024; (59(9)):2321-2337 doi:10.1002/ppul.27068.

    PMID: 38837875
  26. 26

    An efficient and successful outcome after haematopoietic stem cell transplantation in a patient with an LPS-responsive beige-like anchor gene mutation.

    Shen C, Zhang L, Meng Y, et al.

    Frontiers in pediatrics 2024; (12()):1420118 doi:10.3389/fped.2024.1420118.

    PMID: 39108694
  27. 27

    Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party study.

    Tsilifis C, Speckmann C, Lum SH, et al.

    The Journal of allergy and clinical immunology 2024; (154(6)):1534-1544 doi:10.1016/j.jaci.2024.08.020.

    PMID: 39218359
  28. 28

    Inborn errors of immunity and invasive fungal infections: presentation and management.

    Paccoud O, Warris A, Puel A, Lanternier F

    Current opinion in infectious diseases 2024; (37(6)):464-473 doi:10.1097/QCO.0000000000001062.

    PMID: 39259685
  29. 29

    Hematopoietic stem cell transplantation for primary immunodeficiency.

    Alsaati N, Grier A, Ochfeld E, et al.

    Allergy and asthma proceedings 2024; (45(5)):371-383 doi:10.2500/aap.2024.45.240069.

    PMID: 39294909
  30. 30

    Immunodeficiency: Overview of primary immune regulatory disorders (PIRDs).

    Nelson CS, Baloh CH

    Allergy and asthma proceedings 2024; (45(5)):332-339 doi:10.2500/aap.2024.45.240070.

    PMID: 39294916
  31. 31

    International multidisciplinary consensus on the definition and clinical approach for monogenic inflammatory immune dysregulation disorders.

    Alkwai HM, Almaghlouth IA, Mendonça LO, et al.

    Pediatric rheumatology online journal 2025; (23(1)):51 doi:10.1186/s12969-025-01109-z.

    PMID: 40369629
  32. 32

    Radiological Patterns of Pediatric Non-cystic Fibrosis Bronchiectasis: A Retrospective Study From Oman.

    Al Jabri M, Al Humaimi O, Al Yousufi F, et al.

    Cureus 2025; (17(6)):e86516 doi:10.7759/cureus.86516.

    PMID: 40698238
  33. 33

    ITCH Deficiency Causing Immunodeficiency and Immune Dysregulation.

    Hernández A, Cerda C, María Vinet A, et al.

    Pediatrics 2025; (156(5)) doi:10.1542/peds.2024-069311.

    PMID: 41130596
  34. 34

    Case Report: Sustained immune and pulmonary recovery three years after hematopoietic stem cell transplantation for ITCH E3 ubiquitin ligase deficiency.

    Ashe B, Neal E, Kurland G, et al.

    Frontiers in immunology 2026; (17()):1805196 doi:10.3389/fimmu.2026.1805196.

    PMID: 42148098
  35. 35

    Primary Immune Regulatory Disorders (PIRD): Tools for Diagnosis and Disease Activity Assessment to Guide Therapy.

    Oved JH, Torgerson TR, Chan AY

    The journal of allergy and clinical immunology. In practice 2026; (14(7)):1467-1474 doi:10.1016/j.jaip.2026.05.015.

    PMID: 42409454
  36. 36

    Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders.

    Wang C, Durkee-Shock J, Ma CA, et al.

    The journal of allergy and clinical immunology. In practice 2026; (14(7)):1477-1488 doi:10.1016/j.jaip.2026.02.039.

    PMID: 42409455
  37. 37

    Multidisciplinary approach to early identification of inborn errors of immunity in patients with lymphoproliferation.

    Alsina L, Celis Passini V, Garrido Colino C, et al.

    Leukemia & lymphoma 2026; (67(11)):2192-2205 doi:10.1080/10428194.2026.2704265.

    PMID: 42518275
  38. 38

    How I Treat: Transplantation for primary immune regulatory diseases and inflammatory disorders.

    Oved JH

    Journal of human immunity 2026; (2(6)) doi:10.70962/jhi.20250147.

    PMID: 42831798
  39. 39

    Pulmonary Rehabilitation in Inborn Errors of Immunity with Bronchiectasis: A Narrative Review with Implications for High-Consanguinity Settings.

    Alruwaili R, Albelasi A, Alqahtani MM

    Journal of clinical medicine 2026; (15(20)) doi:10.3390/jcm15208131.

    PMID: 42941650